Mersana Therapeutics, Inc. (MRSN)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

22

0

6

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
07-Oct-24 5:48 PM View:	03-Oct-24 Planned Option Sale ($10.97K)	Carvajal Alejandra SVP, Chief Legal Officer		Mersana Therapeutics, Inc. - MRSN	133% 27.4K to 63.72K	0	0	--	--	Show Txns Hide Txns

07-Oct-24 5:47 PM View:	03-Oct-24 Planned Option Sale ($6.59K)	Mandelia Ashish VP, Chief Accounting Officer		Mersana Therapeutics, Inc. - MRSN	84% 25.97K to 47.76K	0	0	--	--	Show Txns Hide Txns

07-Oct-24 5:47 PM View:	03-Oct-24 Planned Option Sale ($10.97K)	Bala Mohan SVP, Chief Development Officer		Mersana Therapeutics, Inc. - MRSN	258% 14.05K to 50.37K	0	0	--	--	Show Txns Hide Txns

13-Sep-24 5:08 PM View:	12-Sep-24 Planned Option Sale ($88.74K)	Huber Martin H. Jr. President, CEO Director		Mersana Therapeutics, Inc. - MRSN	100% 0 to 116.33K	0	0	--	--	Show Txns Hide Txns

07-Oct-24 5:48 PM View:	03-Oct-24 Planned Option Sale ($10.97K)	Deschuytner Brian SVP, COO & CFO		Mersana Therapeutics, Inc. - MRSN	62% 58.51K to 94.82K	0	0	--	--	Show Txns Hide Txns

07-Oct-24 5:46 PM View:	03-Oct-24 Planned Option Sale ($10.97K)	Lowinger Timothy B SVP, Chief Sci.&Tech. Officer		Mersana Therapeutics, Inc. - MRSN	18% 199.33K to 235.64K	0	0	--	--	Show Txns Hide Txns